Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Nov. 17, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ( "Cytokinetics" or the "Company" ) ( NASDAQ:CYTK ) of a class action securities lawsuit.
DEADLINE ALERT for CYTK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Cytokinetics ( NASDAQ:CYTK )
LOS ANGELES, Nov. 17, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
BMY Stock Down on Discontinuation of ACS Clinical Study With JNJ
BMY shares drop after halting the Librexia ACS trial, though other milvexian studies continue with top-line data expected in 2026.
Cytokinetics Supports American Heart Association Initiative to Improve Care for People Living With Hypertrophic Cardiomyopathy
System of Care to Advance Care for the Most Commonly Inherited Heart Disease ...
Cytokinetics Supports American Heart Association Initiative to Improve Care for People Living With Hypertrophic Cardiomyopathy - Cytokinetics ( NASDAQ:CYTK )
System of Care to Advance Care for the Most Commonly Inherited Heart Disease
Cytokinetics Supports American Heart Association Initiative to Improve Care for People Living With Hypertrophic Cardiomyopathy
System of Care to Advance Care for the Most Commonly Inherited Heart Disease
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ...
CYTK LAWSUIT ALERT: Levi & Korsinsky Notifies Cytokinetics, Incorporated Investors of a Class Action Lawsuit and Upcoming Deadline - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ( "Cytokinetics" or the "Company" ) ( NASDAQ:CYTK ) of a class action securities lawsuit.
Cytokinetics Gains 11.4% in a Week: Is There More Room for Growth?
Cytokinetics' shares surge to a 52-week high as investor optimism grows over FDA approval prospects for aficamten.
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. ( NASDAQ:CYTK ) between December 27, 2023 and May 6, 2025, both dates inclusive ( the "Class Period" ) , of the important November 17, ...
Bragar Eagel & Squire, P.C. Reminds Investors of Cytokinetics, Quanex, RCI, and Fortinet to Contact the Firm About their Rights - Cytokinetics ( NASDAQ:CYTK ) , Fortinet ( NASDAQ:FTNT )
NEW YORK, Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Cytokinetics, Incorporated ( NASDAQ:CYTK ) , Quanex Building Products Corporation ...
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Cytokinetics ( CYTK ) Investors - Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Cytokinetics ( NASDAQ:CYTK )
ATLANTA, Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- A shareholder class action lawsuit has been filed against Cytokinetics, Incorporated ( "Cytokinetics" or the "Company" ) ( NASDAQ:CYTK ) . The lawsuit alleges Defendants represented that Cytokinetics expected approval from the U.S.
Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025 - Cytokinetics ( NASDAQ:CYTK )
Three Late Breaking Science Presentations from MAPLE-HCM Provide Additional Data Including Responder Analyses, Patient Reported Outcomes, and Cardiac Biomarkers
Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
Three Late Breaking Science Presentations from MAPLE-HCM Provide Additional Data Including Responder Analyses, Patient Reported Outcomes, and Cardiac ...
ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Nov. 09, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. ( NASDAQ:CYTK ) between December 27, 2023 and May 6, 2025, both dates inclusive ( the "Class Period" ) , of the important November 17, ...
CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit - Cytokinetics ( NASDAQ:CYTK )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Nov. 06, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cytokinetics, Incorporated ( "Cytokinetics" or "the Company" ) ( NASDAQ:CYTK ) and ...
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. ( NASDAQ:CYTK ) between December 27, 2023 and May 6, 2025, both dates inclusive ( the "Class Period" ) , of the important November 17, ...
Cytokinetics ( CYTK ) Q3 2025 Earnings Transcript
Image source: The Motley Fool.Wednesday, Nov. 5, 2025 at 4:30 p.m. ETPresident & Chief Executive Officer - Robert I. BlumContinue reading ...
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact The Gross Law Firm Before November 17, 2025 to Discuss Your Rights - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated ( NASDAQ:CYTK ) . Shareholders who purchased shares of CYTK during the class period listed are encouraged to contact the firm regarding possible lead ...
Cytokinetics ( CYTK ) Reports Q3 Loss, Lags Revenue Estimates
Cytokinetics (CYTK) delivered earnings and revenue surprises of +3.14% and -65.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Cytokinetics Reports Third Quarter 2025 Financial Results and Provides Business Update - Cytokinetics ( NASDAQ:CYTK )
Interactions with FDA Progressing Towards December 26, 2025 PDUFA Date for Aficamten; U.S. Commercial Launch Preparations on Track Ex-U.S. Regulatory Reviews of Aficamten Ongoing in China and E.U. ~$1.25 Billion in Cash, Cash Equivalents and Investments as of September 30, 2025
DEADLINE ALERT for LNTH, VFC, FLR, CYTK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - Cytokinetics ( NASDAQ:CYTK ) , Fluor ( NYSE:FLR )
BENSALEM, Pa., Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK and NEW ORLEANS, Nov. 04, 2025 ( GLOBE NEWSWIRE ) -- Kahn Swick & Foti, LLC ( "KSF" ) and KSF partner, former Attorney General of Louisiana, Charles C.
Cytokinetics to Participate in November Investor Conferences - Cytokinetics ( NASDAQ:CYTK )
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 ( GLOBE NEWSWIRE ) -- Cytokinetics, Incorporated ( NASDAQ:CYTK ) today announced that members of the Company management team will participate in the following investor conferences in November:
CYTK INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics - Cytokinetics ( NASDAQ:CYTK )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In Cytokinetics To Contact Him Directly To Discuss Their Options
CYTOKINETICS CLASS ACTION: Bragar Eagel & Squire, P.C. Urges Cytokinetics Stockholders to Contact the Firm Regarding Their Rights Before November 17th - Cytokinetics ( NASDAQ:CYTK )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Cytokinetics ( CYTK ) To Contact Him Directly To Discuss Their Options
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against V.F. Corporation ( VFC ) , Fluor Corporation ( FLR ) , and Cytokinetics, Incorporated ( CYTK ) - Cytokinetics ( NASDAQ:CYTK ) , Fluor ( NYSE:FLR )
ATLANTA, Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: V.F. Corporation ( VFC ) The shareholder class action lawsuit filed against V.F.
ROSEN, A LEADING AND RANKED FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Oct. 31, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. ( NASDAQ:CYTK ) between December 27, 2023 and May 6, 2025, both dates inclusive ( the "Class Period" ) , of the important November 17, ...
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 ( GLOBE NEWSWIRE ) -- Cytokinetics, Incorporated ( Nasdaq: CYTK ) today announced upcoming presentations, including three Late Breaking Science presentations related to MAPLE-HCM ( Metoprolol vs Aficamten in Patients with LVOT Obstruction on Exercise ...
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025 - Cytokinetics ( NASDAQ:CYTK )
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 ( GLOBE NEWSWIRE ) -- Cytokinetics, Incorporated ( NASDAQ:CYTK ) today announced upcoming presentations, including three Late Breaking Science presentations related to MAPLE-HCM ( Metoprolol vs Aficamten in Patients with LVOT Obstruction on Exercise ...
Cytokinetics, Incorporated Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before November 17, 2025 to Discuss Your Rights - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Oct. 30, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated ( NASDAQ:CYTK ) . Shareholders who purchased shares of CYTK during the class period listed are encouraged to contact the firm regarding possible lead ...
Deadline Alert: Cytokinetics, Incorporated ( CYTK ) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - Cytokinetics ( NASDAQ:CYTK )
LOS ANGELES, Oct. 30, 2025 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 17, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Cytokinetics, Incorporated ( ...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics - Cytokinetics ( NASDAQ:CYTK )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options
Dianthus Therapeutics, Inc. ( DNTH ) Expected to Beat Earnings Estimates: Should You Buy?
Dianthus Therapeutics, Inc. (DNTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW ORLEANS, Oct. 29, 2025 ( GLOBE NEWSWIRE ) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinetics, Incorporated ( NASDAQ:CYTK ) , if they ...
CYTOKINETICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urgently Reminds CYTK Investors to Contact the Firm Before November 17th - Cytokinetics ( NASDAQ:CYTK )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Cytokinetics ( CYTK ) To Contact Him Directly To Discuss Their Options
Earnings Preview: Cytokinetics ( CYTK ) Q3 Earnings Expected to Decline
Cytokinetics (CYTK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK and NEW ORLEANS, Oct. 28, 2025 ( GLOBE NEWSWIRE ) -- Kahn Swick & Foti, LLC ( "KSF" ) and KSF partner, former Attorney General of Louisiana, Charles C.
DEADLINE ALERT for LNTH, VFC, FLR, CYTK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - Cytokinetics ( NASDAQ:CYTK ) , Fluor ( NYSE:FLR )
BENSALEM, Pa., Oct. 28, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
San Francisco is making a comeback. So are these stocks from the City by the Bay
CNBC's Brian Sullivan sought to find the companies based in the city that were making investors the most money this year.
CYTOKINETICS CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Cytokinetics Investors of the Filed Class Action Lawsuit and Urges Investors to Contact the Firm Before November 17th - Cytokinetics ( NASDAQ:CYTK )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Cytokinetics ( CYTK ) To Contact Him Directly To Discuss Their Options
Shareholders of Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Oct. 23, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ( "Cytokinetics" or the "Company" ) ( NASDAQ:CYTK ) of a class action securities lawsuit.
Class Action Filed Against Cytokinetics, Incorporated ( CYTK ) Over Securities Violations - Contact Levi & Korsinsky Today
Class Action Filed Against Cytokinetics, Incorporated (CYTK) Over Securities Violations - Contact Levi & Korsinsky Today ...
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CYTK - Cytokinetics ( NASDAQ:CYTK )
NEW YORK, Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. ( NASDAQ:CYTK ) between December 27, 2023 and May 6, 2025, both dates inclusive ( the "Class Period" ) , of the important November 17, ...
CYTK Investors Should Contact Robbins LLP Regarding the Upcoming Lead Plaintiff Deadline in the Cytokinetics, Inc. Class Action - Cytokinetics ( NASDAQ:CYTK )
SAN DIEGO, Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- Company: Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle ...
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CYTK
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action ...
CYTOKINETICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cytokinetics, Incorporated and Encourages Investors to Contact the Firm - Cytokinetics ( NASDAQ:CYTK )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Cytokinetics ( CYTK ) To Contact Him Directly To Discuss Their Options
Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer
New life sciences executive brings more than 25 years of legal expertise spanning clinical and commercial stage biopharmaceutical companies New life sciences executive brings more than 25 years of legal expertise spanning clinical and commercial stage biopharmaceutical companies ...
CYTK SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
CYTK SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ...
